Financhill
Back

Regeneron Pharmaceuticals Stock Price Chart

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Sell
37

REGN
Regeneron Pharmaceuticals

Last Price:
829.32
Seasonality Move:
11.8%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing slight buying pressure.

Regeneron Pharmaceuticals Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 881.48 Sell
20-day SMA: 945.74 Sell
50-day SMA: 1047.97 Sell
200-day SMA: 1011.95 Sell
8-day EMA: 873.49 Sell
20-day EMA: 932.64 Sell
50-day EMA: 1004.92 Sell
200-day EMA: 999.95 Sell

Regeneron Pharmaceuticals Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -57.31 Sell
Relative Strength Index (14 RSI): 13.94 Sell
Chaikin Money Flow: 109670 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (895.28 - 1026.78) Sell
Bollinger Bands (100): (983.53 - 1152.51) Sell

Regeneron Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Regeneron Pharmaceuticals Stock

Is Regeneron Pharmaceuticals Stock a Buy?

REGN Technical Analysis vs Fundamental Analysis

Sell
37
Regeneron Pharmaceuticals (REGN) is a Sell

Is Regeneron Pharmaceuticals a Buy or a Sell?

Regeneron Pharmaceuticals Stock Info

Market Cap:
91.15B
Price in USD:
829.43
Share Volume:
620.73K

Regeneron Pharmaceuticals 52-Week Range

52-Week High:
1,211.20
52-Week Low:
783.57
Sell
37
Regeneron Pharmaceuticals (REGN) is a Sell

Regeneron Pharmaceuticals Share Price Forecast

Is Regeneron Pharmaceuticals Stock a Buy?

Fundamental Analysis of Regeneron Pharmaceuticals

Is Regeneron Pharmaceuticals a good investment?

  • Analysts estimate an earnings increase this quarter of $2.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.30 per share, and an increase next year of $0.75 per share.

Technical Analysis of Regeneron Pharmaceuticals

Should I short Regeneron Pharmaceuticals stock?

* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.